Atlas Trials

PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days

Clinical trial NCT03808376 · COMPLETED

Trial details

NCT number
NCT03808376
Sponsor
Senseonics, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2018-12-27
Primary completion
2020-05-08
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.